Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-18-054262
Filing Date
2018-02-22
Accepted
2018-02-22 17:07:14
Documents
100
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d516591d10k.htm 10-K 1112649
2 EX-21.1 d516591dex211.htm EX-21.1 1795
3 EX-23.1 d516591dex231.htm EX-23.1 2817
4 EX-31.1 d516591dex311.htm EX-31.1 9322
5 EX-31.2 d516591dex312.htm EX-31.2 9182
6 EX-32.1 d516591dex321.htm EX-32.1 6324
13 GRAPHIC g516591g67u99.jpg GRAPHIC 60205
  Complete submission text file 0001193125-18-054262.txt   8512035

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rgen-20171231.xml EX-101.INS 1646004
8 XBRL TAXONOMY EXTENSION SCHEMA rgen-20171231.xsd EX-101.SCH 71422
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgen-20171231_cal.xml EX-101.CAL 115781
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgen-20171231_def.xml EX-101.DEF 584635
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20171231_lab.xml EX-101.LAB 728524
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20171231_pre.xml EX-101.PRE 680808
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-14656 | Film No.: 18633438
SIC: 2836 Biological Products, (No Diagnostic Substances)